<?xml version="1.0" encoding="UTF-8"?>
<ref id="b86-ir-2019-09155">
 <label>86</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yeo</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>WM</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy</article-title>
  <source>J Clin Oncol</source>
  <year>2004</year>
  <volume>22</volume>
  <fpage>927</fpage>
  <lpage>934</lpage>
  <pub-id pub-id-type="pmid">14990649</pub-id>
 </element-citation>
</ref>
